drugset / Trial / NCT01393522
Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine if milnacipran taken twice daily is effective in reduction of headache pain.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Milnacipran | Other / unclassified | 25 mg | Oral |
| Comparator | Milnacipran | Other / unclassified | 50 mg | Oral |